Methodological notes by company and year

Methodological Notes by Year / Company

Every company disclosing data on Disclosure UK about healthcare professionals (HCPs), other relevant decision makers (ORDMs), and healthcare organisations (HCOs) has provided a Methodological Note which explains how they compiled their data. Please ensure that you consider these notes when you are exploring the data.

To download a full HCP, ORDM and HCO dataset for each year, please visit the Disclosure UK search.

 

A. MENARINI

2025
2024
2023
 

ABBVIE

2025
2024
2023
 

ACCORD

2025
2024
2023
 

ADVANZ UK & IRE

2025
2024
2023
 

AGB

2025
2024
2023
 

AGUETTANT

2025
2024
2023
 

ALEXION

2025
2024
2023
 

ALFASIGMA

2025
2024
-
 

ALIMERA SCIENCES

2025
2024
2023
 

ALK-ABELLO

2025
2024
2023
 

ALLIANCE

2025
2024
2023
 

ALMIRALL

2025
2024
2023
 

ALNYLAM

2025
2024
2023
 

ALTURIX

2025
2024
2023
 

AMGEN

2025
2024
2023
 

AMICUS THERAPUTICS

2025
2024
2023
 

AMRYT

-
2023
-
 

ANGELINI

2025
2024
2023
 

ASCENDIS

2025
2024
-
 

ASPEN

-
2024
-
 

ASTELLAS

2025
2024
2023
 

ASTRAZENECA

2025
2024
2023
 

ATNAHS

2025
2024
2023
 

B. BRAUN MEDICAL

2025
-
-
 

BAUSCH & LOMB

2025
2024
2023
 

BAXTER HEALTHCARE

2025
2024
2023
 

BAYER

2025
2024
2023
 

BESINS HEALTHCARE

2025
2024
2023
 

BIAL

2025
2024
2023
 

BIO PRODUCTS LABORATORY

2025
2024
2023
 

BIOCRYST

2025
2024
2023
 

BIOGEN IDEC

2025
2024
2023
 

BIOMARIN EUROPE

2025
2024
2023
 

BIOPROJET

2025
2024
2023
 

BLUE EARTH DIAGNOSTICS

2025
-
-
 

BLUE EARTH GROUP

-
2024
2023
 

BOEHRINGER INGELHEIM

2025
2024
2023
 

BRACCO

2025
2024
2023
 

BRISTOL-MYERS SQUIBB

2025
2024
2023
 

BRITANNIA

2025
2024
2023
 

CAMURUS

2025
2024
2023
 

CELLTRION HEALTHCARE

2025
2024
2023
 

CHIESI

2025
2024
2023
 

CHUGAI

2025
2024
2023
 

CIPLA

2025
2024
2023
 

CLINUVEL

2025
2024
2023
 

CNX THERAPEUTICS

2025
2024
-
 

CONSILIENT HEALTH

2025
2024
2023
 

CROMA

2025
2024
2023
 

CSL BEHRING

2025
2024
2023
 

DAIICHI SANKYO

2025
2024
2023
 

DERMAL LABORATORIES

2025
2024
2023
 

DIURNAL

-
2024
2023
 

DR FALK

2025
2024
2023
 

ECLOSIX

2025
-
-
 

EISAI

2025
2024
2023
 

ELI LILLY

2025
2024
2023
 

ESTEVE

2025
2024
-
 

ETHYPHARM GROUP

2025
2024
2023
 

EVER

2025
2024
2023
 

EXELTIS

2025
2024
2023
 

FERRING

2025
2024
2023
 

FLYNN

2025
2024
2023
 

FRESENIUS KABI

2025
2024
2023
 

FRESENIUS MEDICAL CARE

2025
2024
2023
 

GALEN

2025
2024
2023
 

GE HEALTHCARE

2025
2024
2023
 

GEDEON RICHTER

2025
2024
2023
 

GILEAD

2025
2024
2023
 

GLAXOSMITHKLINE

2025
2024
2023
 

GRUNENTHAL

2025
2024
2023
 

GUERBET

2025
2024
2023
 

HRA

-
2024
2023
 

IBSA

2025
2024
2023
 

IDORSIA

2025
2024
2023
 

IMMEDICA

2025
2024
2023
 

INCYTE

2025
2024
-
 

INDIVIOR

2025
2024
2023
 

IPSEN

2025
2024
2023
 

IQVIA IES

2025
2024
2023
 

JANSSEN-CILAG

-
2023
-
 

JANSSEN-CILAG (J&J CO)

2025
2024
-
 

JAZZ

2025
2024
2023
 

KALVISTA

2025
-
-
 

KORA

2025
2024
2023
 

L.D. COLLINS

2025
2024
2023
 

LEADIANT BIOSCIENCES

2025
2024
2023
 

LEO

2025
2024
2023
 

LUNDBECK

2025
2024
2023
 

LUPIN

2025
2024
2023
 

LUYE

2025
2024
-
 

MEDICE

2025
2024
2023
 

MENARINI STEMLINE

2025
2024
2023
 

MERCK SERONO

2025
2024
2023
 

MERCK SHARP & DOHME

2025
2024
2023
 

MERZ

2025
2024
2023
 

MITSUBISHI TANABE

2025
2024
2023
 

MODERNA

2025
2024
2023
 

MUNDIPHARMA MEDICAL

2025
2024
2023
 

MUNDIPHARMA RESEARCH

2025
2024
2023
 

NAPP

2025
2024
2023
 

NEON HEALTHCARE

2025
2024
2023
 

NEURAXPHARM

2025
2024
2023
 

NEUROCRINE

2025
-
-
 

NORGINE

2025
2024
2023
 

NOVARTIS

2025
2024
2023
 

NOVO NORDISK

2025
2024
2023
 

OCTAPHARMA

2025
2024
2023
 

ORGANON

2025
2024
2023
 

ORION

2025
2024
2023
 

ORPHALAN

2025
2024
2023
 

OTSUKA

2025
2024
2023
 

OUTLOOK

2025
2024
-
 

PACIRA BIOSCIENCES

2025
2024
2023
 

PAION

2025
2024
2023
 

PARI MEDICAL

2025
2024
2023
 

PFIZER

2025
2024
2023
 

PHARMA NORD

-
2024
2023
 

PHARMAMAR

2025
-
2023
 

PIERRE FABRE

2025
2024
2023
 

PIRAMAL CRITICAL CARE

-
2024
-
 

PROVECA

2025
2024
2023
 

PROVEPHARM

2025
2024
-
 

PTC THERAPEUTICS

2025
2024
2023
 

RECKITT

2025
2024
2023
 

RECORDATI

2025
2024
2023
 

RECORDATI RARE DISEASES

2025
2024
2023
 

RECORDATI UK

2025
2024
-
 

REGENERON

2025
2024
2023
 

RHYTHM

2025
2024
2023
 

ROCHE

2025
2024
2023
 

ROSEMONT

2025
2024
2023
 

SAMSUNG BIOEPIS

2025
2024
2023
 

SANOFI AVENTIS

2025
2024
2023
 

SANTEN

2025
2024
2023
 

SANTHERA

2025
2024
-
 

SEQIRUS

2025
2024
2023
 

SERVIER

2025
2024
2023
 

SHIONOGI BV

2025
2024
2023
 

SIFI

2025
2024
2023
 

SOBI

2025
2024
2023
 

STD PRODUCTS

2025
-
2023
 

STIRLING ANGLIAN

2025
2024
2023
 

SUN

2025
2024
2023
 

SYNER-MED

2025
2024
2023
 

SYRI

-
2023
-
 

TAKEDA

2025
2024
2023
 

TEVA

2025
2024
2023
 

THEA

2025
2024
2023
 

THORNTON & ROSS

2025
-
-
 

TILLOTTS

2025
2024
2023
 

UCB

2025
2024
2023
 

UNITED THERAPEUTICS

2025
-
-
 

VALNEVA

2025
2024
2023
 

VANTIVE

2025
-
-
 

VERITON

2025
2024
2023
 

VIFOR GROUP

2025
2024
2023
 

VISUFARMA

2025
2024
2023
 

ZAMBON

2025
2024
2023
       

Last reviewed date: 01 July 2026

Next review date: 01 July 2029